These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Biotechnology venture capital booms in Japan. Saegusa A Nat Biotechnol; 2000 Mar; 18(3):256. PubMed ID: 10700128 [No Abstract] [Full Text] [Related]
3. Preserving our intellectual capital: the Canadian Institutes of Health Research funding crisis. Phillipson EA CMAJ; 2003 Sep; 169(6):568-9. PubMed ID: 12975224 [No Abstract] [Full Text] [Related]
4. Snaring a venture capital investment. Lytton M Nat Biotechnol; 1998 May; 16 Suppl():54. PubMed ID: 9591272 [No Abstract] [Full Text] [Related]
5. Gold in the ivory tower: equity rewards of outlicensing. Edwards M; Murray F; Yu R Nat Biotechnol; 2006 May; 24(5):509-15. PubMed ID: 16680129 [TBL] [Abstract][Full Text] [Related]
6. Intellectual property as a foundation for funding. Meltzer SL; Marks MS; McCormick JT Nat Biotechnol; 2002 Jul; 20 Suppl():BE47-50. PubMed ID: 12089588 [No Abstract] [Full Text] [Related]
7. The future of biotechnology funding: An interview with venture capitalist Dennis Purcell. Interviewed by Elaine Musgrave. Purcell D Clin Transl Sci; 2009 Oct; 2(5):320-1. PubMed ID: 20443914 [No Abstract] [Full Text] [Related]
8. Industrial health research in Canada. Morin Y CMAJ; 2007 Jun; 176(12):1734; author reply 1734. PubMed ID: 17548390 [No Abstract] [Full Text] [Related]
9. Financing biotechnology in an inefficient market. Purcell DJ Nat Biotechnol; 1999 Feb; 17 Suppl():BE31-2. PubMed ID: 10052324 [No Abstract] [Full Text] [Related]
10. Financing bonanza set to continue. Davidson S Nat Biotechnol; 2000 Sep; 18(9):922-3. PubMed ID: 10973203 [No Abstract] [Full Text] [Related]
11. Filters for preparing to meet a venture capitalist. Christoffersen R Nat Biotechnol; 2003 Jul; 21 Suppl():BE49-50. PubMed ID: 12874981 [No Abstract] [Full Text] [Related]
12. Convincing a venture capitalist to invest in your idea. Dooley JF; Dooley JF Nat Biotechnol; 2003 Jul; 21 Suppl():BE45-8. PubMed ID: 12874980 [No Abstract] [Full Text] [Related]
15. Putting a price on biotechnology. Stewart JJ; Allison PN; Johnson RS Nat Biotechnol; 2001 Sep; 19(9):813-7. PubMed ID: 11533634 [No Abstract] [Full Text] [Related]
16. Research interactions between industry and academia: a corporate perspective. Citron P Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116 [No Abstract] [Full Text] [Related]
18. Developing an intellectual property portfolio for the academic or not-for-profit institution. Bloomberg CA Nat Biotechnol; 2005 Jan; 23(1):119-21. PubMed ID: 15637626 [No Abstract] [Full Text] [Related]
19. The rise of European venture capital for biotechnology. Howell M; Trull M; Dibner MD Nat Biotechnol; 2003 Nov; 21(11):1287-91. PubMed ID: 14595356 [No Abstract] [Full Text] [Related]
20. The rise of venture capital and biotechnology in the US and Europe. Lee DP; Dibner MD Nat Biotechnol; 2005 Jun; 23(6):672-6. PubMed ID: 15940233 [No Abstract] [Full Text] [Related] [Next] [New Search]